Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution-Reference-Cited by-同舟云学术

Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution

Published:2024 Issue: Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Chinnadurai Anu¹^ORCID,Breadner Daniel²³^ORCID,Baloush Ziad²^ORCID,Lohmann Ana Elisa²^ORCID,Black Morgan²^ORCID,D’Souza David²³^ORCID,Welch Stephen²³^ORCID

Affiliation:

1. Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

2. London Regional Cancer Program, London Health Sciences Centre, Victoria Hospital, London, ON, Canada.

3. Department of Oncology, Schulich School of Medicine & Dentistry, Western University, London, ON, Canada.

Publisher

XMLink

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e16

Reference19 articles.

1. Cancer Cancer Society. Canadian cancer statistics 2021 [Internet]. Toronto, ON. Cancer Cancer Society. 2021. cited 2022 Nov 21. Available from: http://www.cancer.ca/Canadian-Cancer-Statistics-2021-EN

2. Endometrial cancer

3. Canadian Cancer Society. Canadian cancer statistics: a 2018 special report on cancer incidence by stage [Internet]. Toronto, ON. Canadian Cancer Society. 2018. cited 2022 Nov 21. Available from: http://www.cancer.ca/Canadian-Cancer-Statistics-2018-EN

4. Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

5. Phase III Trial of Doxorubicin With or Without Cisplatin in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress of Hydrogel in the Application of Gynecologic Malignant Tumor Treatment;Advances in Clinical Medicine;2023